Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Primary Myelofibrosis 19Myeloproliferative Disorders 16Polycythemia Vera 10Leukemia 8Leukemia, Myeloid, Acute 7Breast Neoplasms 6Pancreatic Neoplasms 5Myelodysplastic Syndromes 5Hematologic Diseases 5Thrombocythemia, Essential 4Multiple Myeloma 4Bone Marrow Diseases 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelomonocytic, Chronic 3Graft vs Host Disease 3Thrombocytosis 2Prostatic Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Bronchiolitis Obliterans Syndrome 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Preleukemia 1Precancerous Conditions 1Pathologic Complete Response 1

Interventions

Low-Level Light Therapy 2tremelimumab 1ruxolitinib 1durvalumab 1bavituximab 1Vitamin E 1Tenofovir 1Specimen Handling 1Sorafenib 1Simvastatin 1Pentoxifylline 1Magnetic Resonance Spectroscopy 1Liver Transplantation 1Hypothermia, Induced 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Fibrosis × ruxolitinib × Clear all
NCT01981850 2022-01-05

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

Hoffmann-La Roche

Phase 2 Completed
125 enrolled 38 charts
Myeloid

Fibrosis, Polycythemia Vera, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡